EUVIMEDEUVIMED entdecken
Crossref

Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma

Lingli Xiao iD, Jianhua Zhou iD, Wen Tan, Ying Liu iD, Haoming Zheng iD, Guanying Wang iD, Wei Zheng iD, Xiaoqing Pei iD, Ankui Yang iD, Longzhong Liu iD

Radiology · 01.05.2023 · 307 (4)

DOI: 10.1148/radiol.221465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiology, erschienen am 01.05.2023. Verfasst von Lingli Xiao und 9 weiteren Autor:innen. Beteiligte Einrichtung: From the Departments of Ultrasound (L.X., J.Z., H.Z., G.W., W.Z., X.P., L.L.) and Head and Neck Surgery (A.Y.), Sun Yat-sen University Cancer Center,…. Hauptthemen laut MEDLINE: Thyroid Neoplasms, Carcinoma, Papillary. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although metastasis of lateral cervical lymph nodes (LNs) is common in papillary thyroid carcinoma (PTC), correctly diagnosing small metastatic LNs with US remains challenging. The use of contrast-enhanced US (CEUS), especially the postvascular phase of CEUS with perfluorobutane contrast material, might contribute to improved diagnosis of metastatic LNs in PTC.

Purpose

To assess the diagnostic value of the postvascular phase of CEUS with perfluorobutane in suspicious small lateral cervical LNs (short-axis diameter ≤8 mm) in patients with PTC. Materials and Methods This single-center study prospectively enrolled consecutive participants with confirmed PTC and suspicious LNs at US from October 2020 to October 2021. All participants underwent CEUS, 1 week before biopsy or surgery, with intravenous perfluorobutane contrast material to visualize the LNs in the vascular phase (5-60 seconds after injection) and postvascular phase (10-30 minutes after injection). The reference standard was cytologic and surgical histologic assessment of the LNs. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of sonographic features were calculated, and the diagnostic performance of US, CEUS, and the combination of postvascular phase and US features was assessed using multivariable logistic regression models.

Results

A total of 135 participants (median age, 36 years [IQR, 30-46 years]; 100 women) with 161 suspicious LNs at US were evaluated, including 67 metastatic and 94 benign LNs. The specificity of perfusion defect as a sonographic feature in the vascular phase reached 96% (90 of 94 LNs), and the negative predictive value of non-isoenhancement (ie, hypoenhancement, partial enhancement, and no enhancement) in the postvascular phase reached 100% (83 of 83 LNs). The area under the receiver operating characteristic curve (AUC) of the combination of postvascular phase and US features was 0.94 (95% CI: 0.89, 0.97), significantly higher than that of US features alone (AUC, 0.73; 95% CI: 0.65, 0.79; P < .001).

Conclusion

The postvascular phase of CEUS with perfluorobutane demonstrated excellent performance for diagnosing suspicious small lateral cervical LNs in participants with PTC. Published under a CC BY 4.0 license Supplemental material is available for this article. See also the editorial by Gunabushanam in this issue.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid NeoplasmsCarcinoma, PapillaryHumansFemaleAdultThyroid Cancer, PapillaryLymphatic MetastasisContrast MediaLymph NodesUltrasonographyRetrospective StudiesFluorocarbons

Substanzen

Contrast MediaperfluorobutaneFluorocarbons

Autor:innen und Institutionen

  • From the Departments of Ultrasound (L.X., J.Z., H.Z., G.W., W.Z., X.P., L.L.) and Head and Neck Surgery (A.Y.), Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innova…

ORCID-Profile: Lingli Xiao, Jianhua Zhou, Ying Liu, Haoming Zheng, Guanying Wang, Wei Zheng, Xiaoqing Pei, Ankui Yang, Longzhong Liu

Förderung

  • Natural Science Foundation of Guangdong Province

Zitieren

APA

Xiao, L., Zhou, J., Tan, W., Liu, Y., Zheng, H., Wang, G., Zheng, W., Pei, X., Yang, A., & Liu, L. (2023). Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma. Radiology, 307(4). https://doi.org/10.1148/radiol.221465

Vancouver

Xiao L, Zhou J, Tan W, Liu Y, Zheng H, Wang G, et al. Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma. Radiology. 2023;307(4). doi:10.1148/radiol.221465

BibTeX
@article{Xiao2023,
  author = {Xiao, Lingli and Zhou, Jianhua and Tan, Wen and Liu, Ying and Zheng, Haoming and Wang, Guanying and Zheng, Wei and Pei, Xiaoqing and Yang, Ankui and Liu, Longzhong},
  title = {Contrast-enhanced US with Perfluorobutane to Diagnose Small Lateral Cervical Lymph Node Metastases of Papillary Thyroid Carcinoma},
  journal = {Radiology},
  year = {2023},
  volume = {307},
  number = {4},
  doi = {10.1148/radiol.221465}
}
Kostenlos starten →